Comparison of FDG-PET and dynamic contrast-enhanced MRI in the evaluation of suggestive breast lesions

Breast

Volumn 12, Issue 1, 2003, Pages 17-22

  Heinisch, M ^a   Gallowitsch, H J ^a   Mikosch, P ^a   Kresnik, E ^a   Kumnig, G ^a   Gomez, I ^a   Lind, P ^a   Umschaden, H W ^b   Gasser, J ^b   Forsthuber, E P ^b  

^a Department of Nuclear Medicine and Endocrinology   (Austria)

^b GENERAL HOSPITAL KLAGENFURT   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; GADOLINIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOMAMMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAMMOGRAPHY; MULTIPLE CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

EID: 0037301618     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(02)00262-X     Document Type: Article

References (27)

1. Bjurstam N, Bjorneld L, Duffy S W et al. The Gothenburg Breast Screening Trial: first results on mortality, incidence and mode of detection for woman ages 39-49 years at randomization. Cancer 1997; 80: 2091-2099.
2. Tabar L, Fagerberg G, Chen H H et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer 1995; 75: 2507-2517.
3. Elmore J G, Wells C K, Lee C H, Howard D H, Feinstein A R. Variability in radiologists' interpretations of mammograms. N Engl J Med 1994; 331: 1493-1499.
4. Pollei S R, Mettler Jr F A, Bartow S A, Moradian G, Moskowitz M. Occult breast cancer: prevalence and radiographic detectability. Radiology 1987; 163: 459-462.
5. Kopans D B, Moore R H, McCarthy K A et al. Positive predictive value of breast biopsy performed as a result of mammography: there is no abrupt change at age 50 years. Radiology 1996; 200: 357-360.
6. 99mTc-sestamibi scintimammography and sonography in the diagnostic workup of breast masses. Am J Roentgenol 2000; 174: 1779-1783.
7. Orel S G, Hochmann M G, Schnall M D, Reynolds C, Sullivan D C. High-resolution MR imaging of the breast: clinical context. Radiographics 1996; 16: 1385-1401.
8. Brown R S, Wahl R L. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer 1993; 72: 2979-2985.
9. Avril N, Dose J, Janicke F et al. Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. Eur J Nucl Med 1996; 14: 1848-1857.
10. Avril N, Bense S, Ziegler S I et al. Breast imaging with fluorine-18-FDG PET: quantitative image analysis. J Nucl Med 1997; 38: 1186-1191.
11. Palmedo H, Bender H, Grunwald F et al. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumors. Eur J Nucl Med 1997; 24: 1138-1145.
12. Scheidhauer K, Scharl A, Pietrzyk U et al. Qualitative (18F)FDG positron emission tomography in primary breast cancer: clinical relevance and practicability. Eur J Nucl Med 1996; 23: 618-623.
13. Yutani K, Shiba E, Kusuoka H et al. Comparison of FDG-PET with MIBI-SPECT in the detection of breast cancer and axillary lymph node metastasis. J Comput Assist Tomogr 2000; 24: 274-280.
14. Palmedo H, Bender H, Grunwald F et al. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours. Eur J Nucl Med 1997; 24: 1138-1145.
15. Dehdashti F, Flanagan F L, Mortimer J E, Katzenellenbogen J A, Welch M J, Siegel B A. Positron emission tomography assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy. Eur J Nucl Med 1999; 26: 51-56.
16. Moon D H, Maddahi J, Silverman D H, Glapsy J A, Phelps M E, Hoh C K. Accuracy of whole-body fluorine-18-FDG PET for the detection of reccurrent or metastatic breast carcinoma. J Nucl Med 1998; 39: 431-435.
17. Schelling M, Avril N, Nahrig J et al. Positron emission tomography using [(18)F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol 2000; 18: 1689-1695.
18. Brix G, Henze M, Knopp M V et al. Comparison of pharmacokinetic MRI and (18) fluorodeoxyglucose PET in the diagnosis of breast cancer: initial experience. Eur Radiol 2001; 11: 2058-2070.
19. Brown R S, Leung J Y, Fischer S J, Frey K A, Ethier S P, Wahl R L. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake. J Nucl Med 1996; 37: 1042-1047.
20. Haberkorn U, Ziegler S I, Oberdorfer F et al. FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. Nucl Med Biol 1994; 21(6): 827-834.
21. Crippa F, Seregni E, Agresti R et al. Association between (18F) fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation. Eur J Nucl Med 1998; 25: 1429-1434.
22. Orel S G, Mendonca M H, Reynolds C, Schnall M D, Solin N J, Sullivan D C. MR imaging of ductal carcinoma in situ. Radiology 1997; 202: 413-420.
23. Hiramatsu H, Ikeda T, Mukai M, Masamura S, Kikuchi K, Hiramatsu K. MRI of ductal carcinoma in situ of the breast: patterns of findings and evaluation of disease extent. Nippon Igaku Hoshasen Gakkai Zasshi 2000; 60: 205-209.
24. Bakheet S M, Powe J, Kandil A, Ezzat A, Rostom A, Amartey J. F-18 FDG uptake in breast infection and inflammation. Clin Nucl Med 2000; 25: 100-103.
25. Kinkel H, Helbich T H, Essermann L J et al. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. Am J Roentgenol 2000; 175: 35-43.
26. Hrung J M, Sonnad S S, Schwartz J S, Langlotz C P. Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Acad Radiol 1999; 6: 387-397.
27. Feig S A. Role and evaluation of mammography and other imaging methods for breast cancer detection, diagnosis, and staging. Semin Nucl Med 1999; XXIX (1): 3-15